About Dres.Andreas Ammon und Dirk Meyer
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
iOMEDICO AG
2
Clinical Trials at Dres.Andreas Ammon und Dirk Meyer
During the past decade, Dres.Andreas Ammon und Dirk Meyer conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia
2013-11-04
2018-10-08
Completed
979
A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer
2014-07-14
2020-08-25
Completed
401
Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy
2019-07-10
2021-07-01
Completed
154
Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology
2020-04-17
2023-06-30
Recruiting
500
A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)
2020-10-09
2027-03-18
Active, not recruiting
992
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Dres.Andreas Ammon und Dirk Meyer"
#1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Dres.Andreas Ammon und Dirk Meyer
According to Clinical.Site data, the most researched conditions in "Dres.Andreas Ammon und Dirk Meyer" are
"Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC" (1 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials), "Breast Cancer" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Dres.Andreas Ammon und Dirk Meyer" in a lesser frequency.
Clinical Trials Intervention Types at Dres.Andreas Ammon und Dirk Meyer
Most popular intervention types in "Dres.Andreas Ammon und Dirk Meyer" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (2 trials), "5-Fluorouracil" (1 trials), "Bendamustine" (1 trials), "Chlorambucil" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Dres.Andreas Ammon und Dirk Meyer
The vast majority of trials in "Dres.Andreas Ammon und Dirk Meyer" are
5 trials for "All" genders.
Clinical Trials Status at Dres.Andreas Ammon und Dirk Meyer
Currently, there are NaN active trials in "Dres.Andreas Ammon und Dirk Meyer".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Dres.Andreas Ammon und Dirk Meyer,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dres.Andreas Ammon und Dirk Meyer, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".